<?xml version="1.0" encoding="UTF-8"?><abstracts-retrieval-response xmlns="http://www.elsevier.com/xml/svapi/abstract/dtd" xmlns:ait="http://www.elsevier.com/xml/ani/ait" xmlns:ce="http://www.elsevier.com/xml/ani/common" xmlns:cto="http://www.elsevier.com/xml/cto/dtd" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:xocs="http://www.elsevier.com/xml/xocs/dtd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><coredata><prism:url>http://api.elsevier.com/content/abstract/scopus_id/84897042820</prism:url><dc:identifier>SCOPUS_ID:84897042820</dc:identifier><eid>2-s2.0-84897042820</eid><pubmed-id>23928856</pubmed-id><prism:doi>10.1002/bit.25018</prism:doi><dc:title>Seamless correction of the sickle cell disease mutation of the HBB gene in human induced pluripotent stem cells using TALENs</dc:title><prism:aggregationType>Journal</prism:aggregationType><srctype>j</srctype><citedby-count>11</citedby-count><prism:publicationName>Biotechnology and Bioengineering</prism:publicationName><dc:publisher>John Wiley and Sons Inc.P.O.Box 18667NewarkNJ 07191-8667</dc:publisher><source-id>15477</source-id><prism:issn>10970290</prism:issn><prism:volume>111</prism:volume><prism:issueIdentifier>5</prism:issueIdentifier><prism:startingPage>1048</prism:startingPage><prism:endingPage>1053</prism:endingPage><prism:pageRange>1048-1053</prism:pageRange><prism:coverDate>2014-01-01</prism:coverDate><dc:creator><author auid="26639877100" seq="1"><ce:initials>N.</ce:initials><ce:indexed-name>Sun N.</ce:indexed-name><ce:surname>Sun</ce:surname><ce:given-name>Ning</ce:given-name><preferred-name><ce:initials>N.</ce:initials><ce:indexed-name>Sun N.</ce:indexed-name><ce:surname>Sun</ce:surname><ce:given-name>Ning</ce:given-name></preferred-name><author-url>http://api.elsevier.com/content/author/author_id/26639877100</author-url><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60000745" id="60000745"/></author></dc:creator><dc:description><abstract original="y" xml:lang="eng"><ce:para>Sickle cell disease (SCD) is the most common human genetic disease which is caused by a single mutation of human β-globin (HBB) gene. The lack of long-term treatment makes the development of reliable cell and gene therapies highly desirable. Disease-specific patient-derived human induced pluripotent stem cells (hiPSCs) have great potential for developing novel cell and gene therapies. With the disease-causing mutations corrected in situ, patient-derived hiPSCs can restore normal cell functions and serve as a renewable autologous cell source for the treatment of genetic disorders. Here we successfully utilized transcription activator-like effector nucleases (TALENs), a recently emerged novel genome editing tool, to correct the SCD mutation in patient-derived hiPSCs. The TALENs we have engineered are highly specific and generate minimal off-target effects. In combination with piggyBac transposon, TALEN-mediated gene targeting leaves no residual ectopic sequences at the site of correction and the corrected hiPSCs retain full pluripotency and a normal karyotype. Our study demonstrates an important first step of using TALENs for the treatment of genetic diseases such as SCD, which represents a significant advance toward hiPSC-based cell and gene therapies. Biotechnol. Biotechnol. Bioeng. 2014;111: 1048-1053. © 2013 Wiley Periodicals, Inc.</ce:para></abstract></dc:description><link href="http://api.elsevier.com/content/abstract/scopus_id/84897042820" rel="self"/><link href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84897042820&amp;origin=inward" rel="scopus"/><link href="http://api.elsevier.com/content/search/scopus?query=refeid%282-s2.0-84897042820%29" rel="cited-by"/></coredata><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60000745" id="60000745"><affilname>University of Illinois at Urbana-Champaign</affilname></affiliation><authors><author auid="26639877100" seq="1"><ce:initials>N.</ce:initials><ce:indexed-name>Sun N.</ce:indexed-name><ce:surname>Sun</ce:surname><ce:given-name>Ning</ce:given-name><preferred-name><ce:initials>N.</ce:initials><ce:indexed-name>Sun N.</ce:indexed-name><ce:surname>Sun</ce:surname><ce:given-name>Ning</ce:given-name></preferred-name><author-url>http://api.elsevier.com/content/author/author_id/26639877100</author-url><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60000745" id="60000745"/></author><author auid="7404778848" seq="2"><ce:initials>H.</ce:initials><ce:indexed-name>Zhao H.</ce:indexed-name><ce:surname>Zhao</ce:surname><ce:given-name>Huimin</ce:given-name><preferred-name><ce:initials>H.</ce:initials><ce:indexed-name>Zhao H.</ce:indexed-name><ce:surname>Zhao</ce:surname><ce:given-name>Huimin</ce:given-name></preferred-name><author-url>http://api.elsevier.com/content/author/author_id/7404778848</author-url><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60000745" id="60000745"/><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60000745" id="60000745"/></author></authors></abstracts-retrieval-response>
